Hong Kong, China

Lan Zou

This inventor holds 1 USPTO granted patent. Top assignee: Cheer Global Limited. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lan Zou. Retrieved from https://idiyas.com/inventor/lan-zou-sidiepdh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Lan Zou in Hemoglobin-based Therapeutic Agents

Introduction

Lan Zou is an innovative inventor based in Hong Kong, CN. He has made significant contributions to the field of therapeutic agents, particularly in the development of hemoglobin-based solutions for cancer treatment. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Lan Zou holds a patent for hemoglobin-based therapeutic agents. This patent, which is particularly relevant for treating cancer, includes pharmaceutical compositions and methods of use and preparation. His innovative approach aims to enhance the efficacy of cancer treatments through the use of hemoglobin.

Career Highlights

Lan Zou is associated with Cheer Global Limited, where he continues to push the boundaries of medical research. His dedication to innovation has positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Lan Zou collaborates with talented individuals such as Sui-Yi Kwok and Norman Fung-Man Wai. These partnerships enhance the research environment and foster the exchange of ideas, contributing to the advancement of their collective work.

Conclusion

Lan Zou's contributions to hemoglobin-based therapeutic agents exemplify the impact of innovative thinking in the medical field. His work not only addresses critical health challenges but also paves the way for future advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…